Total Payments
$12,136
2024 Payments
$1,064
Companies
39
Transactions
313
Medicare Patients
1,078
Medicare Billing
$219,605
Payment Breakdown by Category
Food & Beverage$6,620 (54.6%)
Travel$5,226 (43.1%)
Education$290.12 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,620 | 279 | 54.6% |
| Travel and Lodging | $5,226 | 20 | 43.1% |
| Education | $290.12 | 14 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Noah Medical Corporation | $2,942 | 16 | $0 (2023) |
| Pulmonx Corporation | $2,117 | 15 | $0 (2024) |
| Intuitive Surgical, Inc. | $1,694 | 14 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $1,279 | 60 | $0 (2023) |
| United Therapeutics Corporation | $1,221 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $844.20 | 53 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $238.94 | 13 | $0 (2022) |
| Merck Sharp & Dohme LLC | $211.92 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $159.19 | 11 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $139.13 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,064 | 19 | Pulmonx Corporation ($474.20) |
| 2023 | $6,809 | 51 | Noah Medical Corporation ($2,942) |
| 2022 | $442.40 | 22 | United Therapeutics Corporation ($207.25) |
| 2021 | $952.74 | 56 | GlaxoSmithKline, LLC. ($247.91) |
| 2020 | $545.54 | 29 | Actelion Pharmaceuticals US, Inc. ($234.62) |
| 2019 | $1,111 | 62 | Actelion Pharmaceuticals US, Inc. ($420.49) |
| 2018 | $586.48 | 35 | Actelion Pharmaceuticals US, Inc. ($159.79) |
| 2017 | $624.76 | 39 | GlaxoSmithKline, LLC. ($169.69) |
All Payment Transactions
313 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: PULMONOLOGY | ||||||
| 12/17/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $40.53 | General |
| Category: PULMONOLOGY | ||||||
| 11/20/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $127.06 | General |
| Category: PULMONOLOGY | ||||||
| 10/17/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: PULMONOLOGY | ||||||
| 09/17/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $98.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/06/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $129.73 | General |
| Category: PULMONOLOGY | ||||||
| 07/23/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: PULMONOLOGY | ||||||
| 07/19/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 06/28/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 05/29/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $31.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/29/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), PULMONX CHARTIS TABLET CONSOLE, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: PULMONOLOGY | ||||||
| 05/21/2024 | United Therapeutics Corporation | TYVASO (Drug), ORENITRAM, REMODULIN | Food and Beverage | In-kind items and services | $119.67 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 05/20/2024 | United Therapeutics Corporation | ORENITRAM (Drug), REMODULIN, TYVASO | Food and Beverage | In-kind items and services | $59.10 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 05/19/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $97.99 | General |
| Category: PULMONOLOGY | ||||||
| 04/17/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 03/15/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $126.13 | General |
| 01/12/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/31/2023 | Noah Medical Corporation | — | Travel and Lodging | Cash or cash equivalent | $1,124.44 | General |
| Category: Pulmonary Disease | ||||||
| 12/22/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: PAH | ||||||
| 12/20/2023 | Noah Medical Corporation | — | Travel and Lodging | Cash or cash equivalent | $640.00 | General |
| Category: Pulmonary Disease | ||||||
| 12/20/2023 | Noah Medical Corporation | — | Travel and Lodging | Cash or cash equivalent | $250.25 | General |
| Category: Pulmonary Disease | ||||||
| 12/15/2023 | Noah Medical Corporation | — | Food and Beverage | Cash or cash equivalent | $129.48 | General |
| Category: Pulmonary Disease | ||||||
| 12/12/2023 | Noah Medical Corporation | — | Food and Beverage | Cash or cash equivalent | $72.18 | General |
| Category: Pulmonary Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 274 | 554 | $141,819 | $67,295 |
| 2022 | 7 | 192 | 303 | $92,215 | $31,831 |
| 2021 | 8 | 365 | 577 | $180,760 | $62,594 |
| 2020 | 7 | 247 | 440 | $149,055 | $57,885 |
Total Patients
1,078
Total Services
1,874
Medicare Billing
$219,605
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 95 | 286 | $99,306 | $45,987 | 46.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 51 | 123 | $18,597 | $11,199 | 60.2% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 24 | 28 | $4,508 | $2,162 | 48.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 16 | 16 | $4,304 | $2,047 | 47.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $3,960 | $1,860 | 47.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 15 | 17 | $3,638 | $1,757 | 48.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 23 | $3,312 | $1,584 | 47.8% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 15 | 15 | $3,615 | $520.13 | 14.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 13 | 15 | $315.00 | $117.30 | 37.2% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 11 | 11 | $264.00 | $62.50 | 23.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 58 | 127 | $64,456 | $21,173 | 32.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 41 | 76 | $15,212 | $6,061 | 39.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 23 | $5,796 | $2,421 | 41.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 22 | $5,566 | $1,730 | 31.1% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 17 | 17 | $408.00 | $160.08 | 39.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 19 | 19 | $435.00 | $153.44 | 35.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 19 | 19 | $342.00 | $133.12 | 38.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 93 | 248 | $134,917 | $44,785 | 33.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 64 | 112 | $22,715 | $9,168 | 40.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 39 | $9,800 | $3,602 | 36.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 25 | 25 | $6,649 | $2,696 | 40.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $3,619 | $1,225 | 33.8% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2021 | 44 | 44 | $1,056 | $400.12 | 37.9% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 48 | 48 | $1,104 | $377.26 | 34.2% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 50 | 50 | $900.00 | $340.17 | 37.8% |
About Dr. Niraj Niraula, MD
Dr. Niraj Niraula, MD is a Internal Medicine healthcare provider based in Youngstown, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2011. The National Provider Identifier (NPI) number assigned to this provider is 1215223722.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Niraj Niraula, MD has received a total of $12,136 in payments from pharmaceutical and medical device companies, with $1,064 received in 2024. These payments were reported across 313 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,620).
As a Medicare-enrolled provider, Niraula has provided services to 1,078 Medicare beneficiaries, totaling 1,874 services with total Medicare billing of $219,605. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Youngstown, OH
- Active Since 06/22/2011
- Last Updated 10/12/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1215223722
Products in Payments
- Da Vinci Surgical System (Device) $1,694
- ZEPHYR ENDOBRONCHIAL VALVE (Device) $1,513
- TYVASO (Drug) $729.46
- NUCALA (Biological) $605.83
- CHARTIS CATHETER (Device) $603.96
- OPSUMIT (Drug) $457.09
- UPTRAVI (Drug) $406.13
- ORENITRAM (Drug) $267.85
- OPSUMIT MACITENTAN (Drug) $224.40
- DUPIXENT (Biological) $135.05
- ACTHAR (Biological) $120.71
- TRELEGY ELLIPTA (Drug) $110.78
- OFEV (Drug) $95.60
- Xyrem (Drug) $91.85
- ZERBAXA (Drug) $88.36
- ANDEXXA (Biological) $81.39
- Briviact (Drug) $77.39
- ANORO (Drug) $76.24
- SYMBICORT (Drug) $70.64
- Adempas (Drug) $64.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Youngstown
John Marakas, M.d, M.D
Internal Medicine — Payments: $23,401
Internal Medicine $23,401
Dr. Maged Awadalla, M.d, M.D
Internal Medicine — Payments: $10,957
Internal Medicine $10,957
Jessica Reiter, D.o, D.O
Internal Medicine — Payments: $8,827
Internal Medicine $8,827
Robert Spratt, Md, MD
Internal Medicine — Payments: $8,743
Internal Medicine $8,743
Edward Miller, Md, MD
Internal Medicine — Payments: $7,843
Internal Medicine $7,843
Santuccio Ricciardi, Md, MD
Internal Medicine — Payments: $7,312
Internal Medicine $7,312